Metropolitan Life Insurance CO Cin Cor Pharma, Inc. Transaction History

Metropolitan Life Insurance CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jun 14, 2023	BUY	$10.75 - $29.84 $17,651 - $48,997	1,642 New	1,642 $20.2 Million
Q4 2022 Mar 30, 2023	BUY	$10.75 - $29.84 $3,687 - $10,235	343 Added 26.4%	1,642 $20,000
Q4 2022 Feb 15, 2023	BUY	$10.75 - $29.84 $3,687 - $10,235	343 Added 26.4%	1,642 $20,000
Q3 2022 Jun 14, 2023	BUY	$19.9 - $38.94 $25,850 - $50,583	1,299 New	1,299 $42.6 Million
Q3 2022 Mar 30, 2023	BUY	$19.9 - $38.94 $6,984 - $13,667	351 Added 37.03%	1,299 $36,000
Q3 2022 Nov 14, 2022	BUY	$19.9 - $38.94 $6,984 - $13,667	351 Added 37.03%	1,299 $43,000
Q2 2022 Jun 20, 2023	BUY	$13.67 - $25.74 $12,959 - $24,401	948 New	948 $17,000
Q1 2022 Jun 20, 2023	BUY	$14.13 - $28.49 $13,395 - $27,008	948 New	948 $16,000
Q1 2022 Mar 30, 2023	SELL	$14.13 - $28.49 $9,806 - $19,772	-694 Reduced 42.27%	948 $16,000
Q1 2022 May 12, 2022	BUY	$14.13 - $28.49 $13,395 - $27,008	948 New	948 $17,000

Ticker CINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,764,300
Description
CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.